2seventy bio(TSVT) - 2024 Q1 - Quarterly Report
2seventy bio2seventy bio(US:TSVT)2024-05-09 20:03
Transcript

UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 FORM 10-Q ☐ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ________ For the quarterly period ended March 31, 2024 Commission file number 001-40791 2seventy bio, Inc. (Exact name of registrant as specified in its charter) Delaware 86-3658454 (State or other jurisd ...